State Board Of Administration Of Florida Retirement System Morphic Holding, Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$51.5 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$26.12 - $34.07 $2,612 - $3,407	100 Added 0.91%	11,145 $379,000
Q1 2024 May 08, 2024	BUY	$26.64 - $40.31 $31,968 - $48,372	1,200 Added 12.19%	11,045 $388,000
Q3 2023 Nov 08, 2023	BUY	$21.33 - $59.42 $25,809 - $71,898	1,210 Added 14.01%	9,845 $225,000
Q2 2023 Aug 11, 2023	SELL	$34.33 - $62.11 $82,735 - $149,685	-2,410 Reduced 21.82%	8,635 $495,000
Q4 2022 Feb 07, 2023	SELL	$24.14 - $30.37 $172,601 - $217,145	-7,150 Reduced 39.3%	11,045 $295,000
Q2 2022 Aug 05, 2022	SELL	$19.74 - $43.01 $102,884 - $224,168	-5,212 Reduced 22.27%	18,195 $395,000
Q1 2022 May 06, 2022	BUY	$36.25 - $52.02 $522,435 - $749,712	14,412 Added 160.22%	23,407 $940,000
Q2 2021 Aug 10, 2021	BUY	$45.13 - $64.99 $199,880 - $287,840	4,429 Added 97.0%	8,995 $516,000
Q1 2021 May 10, 2021	BUY	$29.77 - $84.85 $135,929 - $387,425	4,566 New	4,566 $289,000

Others Institutions Holding MORF

# of Institutions

Shares Held

4.71M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

3.53M
Shares

$201 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

1.06M
Shares

$60.5 Million
0.07% of portfolio
Ea Series Trust Havertown, PA

49.3K
Shares

$2.81 Million
0.1% of portfolio
Credit Suisse Ag Zurich, V8

32.2K
Shares

$1.84 Million
0.0% of portfolio
Teachers Retirement System Of The State Of Kentucky Frankfort, KY

17.2K
Shares

$978,347
0.01% of portfolio

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account